FDA approves new drug to treat adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

From https://www.news-medical.net/news/20190327/FDA-approves-new-drug-to-treat-adults-with-relapsing-forms-of-MS.aspx

from
https://healthnews010.wordpress.com/2019/03/27/fda-approves-new-drug-to-treat-adults-with-relapsing-forms-of-ms/

from https://karlfletcher.blogspot.com/2019/03/fda-approves-new-drug-to-treat-adults.html

from
https://karlfletcher1.tumblr.com/post/183744466643

From https://davidrawlins1.blogspot.com/2019/03/fda-approves-new-drug-to-treat-adults.html

from
https://davidrawlins1.wordpress.com/2019/03/27/fda-approves-new-drug-to-treat-adults-with-relapsing-forms-of-ms/